SOPHiA GENETICS SA Ordinary Shares (SOPH) is a publicly traded Healthcare sector company. As of October 20, 2026, SOPH trades at $6.46 with a market cap of $572.91M and a P/E ratio of 0.00. SOPH moved +0.00% today. Year to date, SOPH is +38.97%; over the trailing twelve months it is +50.58%. Its 52-week range spans $2.58 to $8.98. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces SOPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SOPH, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $6.46 |
| Market Cap | $572.91M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.98 |
| 52-Week Low | $2.58 |
| Volume | 7.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover SOPH: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.